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Abstract 
Genetic alterations in the TGF signaling pathway in combination with oncogenic alterations 
lead to cancer development in the intestines.  However, the mechanism(s) of TGF signaling 
suppression in malignant progression of intestinal tumors has not yet fully understood.  We 
have examined Apc716 Tgfbr2IEC compound mutant mice that carry mutations in Apc and 
Tgfbr2 genes in the intestinal epithelial cells.  We found inflammatory microenvironment only 
in the invasive intestinal adenocarcinomas but not in non-invasive benign polyps of the same 
mice.  We thus treated simple Tgfbr2IEC mice with dextran sodium sulfate (DSS) that causes 
ulcerative colitis.  Importantly, these Tgfbr2IEC mice developed invasive colon cancer 
associated with chronic inflammation.  We also found that TGF signaling is suppressed in 
human colitis-associated colon cancer cells.  In the mouse invasive tumors, macrophages 
infiltrated and expressed MT1-MMP, causing MMP2 activation.  These results suggest that 
inflammatory microenvironment contributes to submucosal invasion of TGF 
signaling-repressed epithelial cells through activation of MMP2.  We further found that 
regeneration was impaired in Tgfbr2IEC mice for intestinal mucosa damaged by DSS 
treatment or X-ray irradiation, resulting in the expansion of undifferentiated epithelial cell 
population.  Moreover, organoids of intestinal epithelial cells cultured from irradiated 
Tgfbr2IEC mice formed ‘long crypts’ in Matigel, suggesting acquisition of an invasive 
phenotype into extracellular matrix.  These results, taken together, indicate that a simple 
genetic alteration in TGF signaling pathway in the inflamed and regenerating intestinal 
mucosa can cause invasive intestinal tumors.  Such a mechanism may play a role in the 
colon carcinogenesis associated with inflammatory bowel disease in humans.   
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Introduction 
Accumulating evidence indicates that inflammatory responses play an important role in 
cancer development (1, 2).  The disruption of genes encoding cyclooxygenase 2 (COX-2) or 
prostaglandin E2 (PGE2) receptor, EP2, in Apc716 knockout mice results in significant 
suppression of intestinal polyposis (3, 4).  Moreover, blocking transcription factors NF-B 
and Stat3 in a chemically-induced colitis-associated colon tumor model in mice causes 
suppression of colon tumor development (5-7).  These results indicate that activation of 
inflammatory pathways through PGE2, NF-B and Stat3 is required for intestinal 
tumorigenesis.  However, it has not yet been elucidated what role the inflammatory 
responses play in the progression of benign intestinal tumors to invasive adenocarcinomas. 
Most intestinal adenomas are induced by APC mutations, resulting in the Wnt signaling 
activation, and tumors progress to adenocarcinomas by additional mutations such as those 
encoding RAS or transforming growth factor  (TGF) type II receptor (TGFRII) (8).  Mouse 
genetic studies have indicated that suppression of TGF signaling accelerates development 
of malignant intestinal tumors in combination with mutations in Kras or Pten, although TGF 
suppression alone does not cause tumorous changes (9, 10).  These results indicate that 
suppression of the TGF signaling is a key process involved in the malignant progression.   
The TGF ligand binds TGFRII, followed by the activation of TGFRI.  Activated 
TGFRI then phosphorylates Smad2/3, which causes their binding with Smad4, and the 
Smad complex induces transcription of TGF target genes (11).  We have previously shown 
that immature myeloid cells (iMCs) are recruited and express matrix metalloproteinase 2 
(MMP2) at the invasion front of compound Apc716 Smad4 knockout mouse intestinal 
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adenocarcinomas, which contribute to their submucosal invasion (12,13).  Moreover, 
disruption of Tgfbr2, encoding TGFRII, in mouse mammary tumor cells results in the 
recruitment of myeloid cells into tumor tissues, which promotes tumor metastasis through a 
process involving metalloproteinase activation (14).  These results indicate that suppression 
of TGF signaling generates a microenvironment that is critical for progression of intestinal 
tumors.  However, it is not understood how the inflammatory responses affect the tumor 
progression induced by TGF suppression.  Moreover, it has not been elucidated whether 
TGF-suppressed epithelial cells acquire an invasive phenotype in tumor tissues. 
We herein show that ulcerative colitis causes submucosal invasion of Tgfbr2-disrupted 
intestinal epithelia, leading to the development of invasive colon cancer.  Moreover, TGF 
signaling suppression in regenerating epithelia caused long crypt formation in Matrigel, which 
may reflect an increased capacity for invasion.  We also found that TGF signaling is 
suppressed in human colitis-associated colon cancer cells.  These results provide a novel 
mechanism for the development of invasive colon cancer where TGF signaling suppression, 
chronic inflammation and the regeneration of epithelial cells are compounded.   
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Materials and Methods 
Animal models 
Wild-type C57BL/6 mice were purchased from CLEA (Osaka, Japan).  Apc716 mice, 
Tgfbr2flox/flox mice, and villin-CreER mice have been described previously (15-17).  
Tgfbr2flox/flox mice were obtained from Mouse Repository (NCI-Frederick, Strain Number: 
01XN5, Frederick, MD).  All animal experiments were carried out according to the protocol 
approved by the Committee on Animal Experimentation of Kanazawa University, Japan. 
 
Animal experiments 
Apc716 Tgfbr2flox/flox villin-CreER mice were treated with tamoxifen (Tmx) at 4 mg/mouse 
once a week, from five weeks of age to generate Apc716 Tgfbr2IEC mice.  Intestinal tumors 
of Apc716 mice and Apc716 Tgfbr2IEC mice were examined at 15 weeks of age (n=4).   
For the dextran sodium sulfate (DSS) treatment experiments, Tgfbr2flox/flox villin-CreER 
mice were treated with Tmx at 4 mg/mouse for three consecutive days to generate Tgfbr2IEC 
mice, and mice were treated with 2% DSS in drinking water (MP Biomedicals, Cambridge, 
UK) for five days.  After DSS treatment, Tgfbr2IEC mice were treated with Tmx for two days, 
and were examined at three days, four weeks, six to ten weeks (n=10 for each) or 40 weeks 
(n=2) post-DSS treatment.   
For the X-ray irradiation experiments, C57BL/6 mice and Tgfbr2IEC mice were irradiated 
with X-ray at 9 Gy (n=15 for each), and were examined for the intestine phenotype 
chronologically from days 0 to 6.   
For azoxymethane (AOM)/DSS colitis-associated colon tumor model, wild-type mice 
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(n=10) were intraperitoneally injected with 10 mg/kg AOM (Sigma, St. Louis, MO), followed by 
treatment with 2.0% DSS (MP Biomedicals, Cambridge, UK) in drinking water for five days 
(week 1).  This cycle was repeated twice during weeks 4 and 7, and mice were euthanized at 
week 15.  Tumor tissues were used for immunoblotting analysis and gelatin zymography. 
 
Histology and immunohistochemistry 
The tissue sections were stained with H&E or Masson’s trichrome stain, or were 
processed for immunohistochemistry.  Staining signals of immunohistochemistry were 
visualized using the Vectastain Elite Kit (Vector Laboratories, Burlingame, CA).  Antibodies 
against E-cadherin (R&D, Minneapolis, MN), -SMA (Sigma, St. Louis, MO), F4/80 (Serotec, 
Oxford, UK), MT1-MMP (Gene Tex, Irvine, CA), Ki67 (Life technologies, Grand Island, NY), 
GFP (Molecular Probes, Eugene, OR), Collagen type IV (Nichirei Biosciences, Tokyo, Japan), 
CD44 (Millipore, Billerica, MA), SOX7 (R&D, Minneapolis, MN), phosphorylated Smad2 
(P-Smad2) at Ser465/467 (Millipore, Billerica, MA) and -catenin (Sigma, St Louis, MO) were 
used for immunohistochemistry.  For fluorescence immunohistochemistry, Alexa Fluor 594 or 
Alexa Fluor 488 antibodies (Molecular Probes, Eugene, OR) were used as the secondary 
antibody.  Approval for the project using human tissue sections was obtained from the Tokyo 
Medical and Dental University Hospital Ethics Committee.  
 
Bone marrow transplantation 
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Bone marrow (BM) cells were prepared from the femurs and tibias of green fluorescent 
protein (GFP) gene transgenic mice.  Recipient mice were irradiated with 9 Gy of X-rays, 
followed by intravenous injection of 2 × 106 BM cells.   
 
Real-time reverse transcription-polymerase chain reaction (RT-PCR) 
Size-classified intestinal polyps and normal intestines of Apc716 mice (n=5 for each) were 
used for RNA extraction.  For DSS-treated mouse samples, normal colon tissues or invasive 
colon tumors at three days, four weeks or six to ten weeks (n=10 for each) post-DSS 
treatment were used for RNA extraction.  The total RNAs were reverse-transcribed using the 
PrimeScript RT reagent kit (Takara, Tokyo, Japan) and were PCR-amplified using SYBR 
Premix ExTaqII (Takara, Tokyo, Japan).  The primers used for the real-time RT-PCR were 
purchased from Takara. 
 
Immunoblotting analysis 
Tissues were homogenized in lysis buffer, and protein sample was separated in a 10% 
SDS-polyacrylamide gel.  Antibodies against active form of -catenin (dephosphorylated at 
Ser37 and Thr41) (Millipore, Billerica, MA) and total -catenin (Sigma, St. Louis, MO), Stat3 
(Cell Signaling, Danvers, MA) and phosphorylated Stat3 at Tyr705 (Cell Signaling, Danvers, 
MA) were used.  An anti-β-actin antibody (Sigma, St Louis, MO) was used as the internal 
control.  The ECL detection system (GE Healthcare, Buckinghamshire, UK) was used to 




Tissue sample was lysed in SDS sample buffer, incubated for 20 min at 37°C and 
separated in a 10% polyacrylamide gel containing 0.005% gelatin labeled with Alexa Fluor 
670 (Abcam, Cambridge, UK).  After electrophoresis, gels were soaked in 2.5% Triton X-100 
for 1 h, then gelatinolysis was carried out by incubation at 37°C for 24 h.  The gel was 
monitored by an OdysseyTM infrared imaging system (LI-COR, Lincoln, NE).  
 
Organoid culture 
The organoid culture using small intestinal epithelial cells was performed as described 
previously (18).  Briefly, organoids were cultured in Matrigel with Advanced DMEM/F12 
medium (Invitrogen, Carlsbad, CA) supplemented with 50 ng/ml EGF (Invitrogen, Carlsbad, 
CA), R-Spondin1 conditioned medium (a kind gift from Dr. Marc Leushacke) and 100 ng/ml 
Noggin (Peprotech, Rocky Hill, NJ).  The cultures were passaged once, and the crypt length 
was measured under a dissecting microscope.   
Organoid cell proliferation was detected using the Click-iT EdU Imaging System 
(Invitrogen, Carlsbad, CA).  After EdU staining, organoids were incubated with anti-CD44 
antibody (Chemicon, Temecula, CA) followed by secondary antibody, Alexa Fluor 488 
(Molecular Probes, Eugene, OR).  The stained organoids were analyzed using a Zeiss 510 




The data were analyzed using an unpaired t-test, and are presented as the means ± 
standard deviation (s.d.).  A value of P < 0.05 was considered as statistically significant. 
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Results 
Size-dependent submucosal invasion of intestinal tumors 
It has been demonstrated that the disruption of Tgfbr2, Smad4 or Smad3 in Apc mutant 
mice causes development of invasive adenocarcinomas in the intestine, whereas simple Apc 
mutant mice develop only benign adenomas (12, 19-21).  Accordingly, the combination of 
Wnt signaling activation and TGF signaling suppression is implicated in the malignant 
invasion of intestinal tumors.  To further investigate the mechanism underlying the 
submucosal invasion of intestinal tumors, we constructed compound mutant mice carrying 
both Apc716 and Tgfbr2 mutation in intestinal epithelial cells (Apc716Tgfbr2IEC).  We 
confirmed that Apc716 Tgfbr2IEC mice developed adenocarcinomas with submucosal 
invasion, whereas simple Apc716 mice had only non-invasive adenomas (Fig. 1A and 
Supplementary Fig. S1).  Notably, only the polyps > 1 mm in diameter showed submucosal 
invasion in the Apc716 Tgfbr2IEC mice (Fig. 1B and Supplementary Fig. S1B).  Histologically, 
large invasive polyps in Apc716 Tgfbr2IEC mice were associated with increased stroma and 
macrophage infiltration, which was not found in the small non-invasive polyps (Fig. 1C).  
Metalloproteinase-1 (MT1-MP) expression was induced in the stroma of the large invasive 
tumors, and collagen fiber deposition was also found in the stroma by Masson’s trichrome 
staining.  Moreover, expression of IL-1, IL-6 and COX-2 was induced when polyp size 
increased beyond > 1 mm in diameter in Apc716 mouse small intestine, and expression levels 
of MT1-MMP, Adam10 and epiregulin were also increased in the large polyps (Fig. 1D).  The 
induction of these factors was also found in the colon polyps > 2 mm in diameter.  By a laser 
microdissection-based RT-PCR analysis, we found that these factors, except for Adam10, 
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were predominantly expressed in the tumor stroma (Supplementary Fig. S2).  Taken together, 
these results indicate that the inflammatory microenvironment is generated by a tumor 
size-dependent mechanism in both the small intestinal and colon polyps.  It is therefore 
possible that such microenvironment is required for submucosal invasion.  
 
Submucosal invasion by TGF signaling suppression and ulcerative colitis 
We thus examined the role of inflammatory responses in TGF signaling 
suppression-associated submucosal invasion using a colitis mouse model by treating 
Tgfbr2IEC mice with DSS (Fig. 2A).  The wild-type mice treated with DSS showed ulcerative 
colitis beginning three days after DSS treatment, and the colonic mucosa was repaired in four 
weeks post-treatment (Fig. 2B).  Although mucosal ulcers were repaired in the Tgfbr2IEC 
mice in four weeks post-DSS treatment, regeneration of the normal gland structure was 
significantly impaired (Fig. 2B, asterisk).  Importantly, colonic epithelial cells invaded to the 
submucosa in Tgfbr2IEC mice by the end of fourth week post-treatment.  These invading 
epithelial cells continued proliferation, and formed invasive tumors associated with deposition 
of collagen fibers by the 10 weeks post DSS treatment (Fig. 2C).  Furthermore, large solid 
tumors were visible from outside of the colon and cecum of Tgfbr2IEC mice by the 40th week 
post-treatment (Fig. 2D).  Epithelial cells of tumors were positive for Ki67, indicating that the 
tumor cells continued proliferation even at 40 weeks post-DSS treatment.  We confirmed that 
disruption of Tgfbr2 in normal intestinal mucosa did not cause any morphological changes 
(Supplementary Fig. S3), which is consistent with previous reports (20, 22).  The level of 
active -catenin was significantly increased both in the Apc716 mouse intestinal tumors and 
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colitis-associated colon tumors that were chemically induced by treatment with AOM and DSS, 
however, active -catenin level was not increased in the invasive tumors of DSS-treated 
Tgfbr2IEC mice (Fig. 2E).  These results indicate that ulcerative colitis induces invasive 
tumors in the TGF-suppressed mucosa without activation of the Wnt signaling. 
We next examined human inflammatory bowel disease (IBD)-related colon cancer.  
Nuclear localized P-Smad2 was found in the surface epithelial cells of ulcerative colitis (UC), 
however, it was not detected in the invaded tumor cells, indicating that there was suppression 
of TGF signaling (Fig. 2F).  A loss of P-Smad2 staining in tumor cells was found in five out 
of eight cases (62.5%) of UC-associated colon cancer.  Moreover, -catenin accumulation 
was not detected in seven out of eight UC-associated tumors (87.5%).  Accordingly, it is 
possible that suppression of TGF signaling causes colon cancer invasion in human IBD 
patients without Wnt signaling activation. 
 
Chronic inflammatory responses in the invasive tumors 
We found that bone marrow-derived cells and macrophages infiltrated in the stroma of 
invasive colon tumors, but not in the non-invasive mucosa of DSS-treated Tgfbr2IEC mice (Fig. 
3A).  Consistently, expression of monocyte-trophic chemokines (23), CCL2, CCL3, CCL4, 
CCL7 and CCL8, was increased significantly in the invasive colon tumors (Fig. 3B).  
Moreover, Stat3 was constitutively phosphorylated in the invasive tumors of DSS-treated 
Tgfbr2IEC mice, whereas its level was decreased in the repaired mucosa of DSS-treated 
wild-type mice (Fig. 3C).  These results indicate that inflammatory responses are chronically 
maintained in the invasive tumor tissues, even after the repair of DSS-induced ulcers. 
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We thus determined the levels of inflammatory cytokines in both the invasive tumors 
and DSS-induced ulcerative colitis.  Expression was significantly upregulated for TNF-, 
IL-1, IL-6, CXCL1, CXCL2 and COX-2 by DSS-induced ulcerative colitis in both the wild-type 
andTgfbr2IEC mice (Fig. 3D, yellow and blue circles, respectively), whereas the levels of 
these factors in wild-type mice decreased significantly after the mucosa was repaired (Fig. 3D, 
green circles).  In the invasive tumors of the Tgfbr2IEC mice, expression of TNF-, IL-6 and 
CXCL2 remained high, whereas that of IL-1, CXCL1 and COX-2 decreased to the level of 
repaired mucosa (Fig. 3D, red circles).  These results indicate that different types of 
inflammatory responses are induced in the invasive tumor tissues of the Tgfbr2IEC mice 
compared with those in the mice with DSS-induced acute colitis. 
 
Expression of MT1-MMP and activation of MMP2 in invasive tumors 
To investigate the mechanism underlying chronic inflammation-associated invasion, we 
examined expression of MMPs that are important for submucosal invasion (24).  It has been 
shown that MT1-MMP plays a key role in activation of MMP2 (25) and MT1-MMP is 
expressed in macrophages, regulating inflammatory responses (26, 27).  The expression 
levels of MT1-MMP, MMP2 and MMP9 were significantly increased in the invasive tumors of 
DSS-treated Tgfbr2IEC mice (Fig. 4A).  Fluorescence immunohistochemistry showed that 
the stromal cells of invasive tumors expressed MT1-MMP, and most MT1-MMP-expressing 
cells in tumor stroma were F4/80-positive macrophages (Fig. 4B).  Moreover, gelatin 
zymography analyses revealed that MMP2 was activated in the invasive tumor tissues, but 
not in the normal colonic mucosa of the same DSS-treated Tgfbr2IEC mice (Fig. 4C).  
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Consistently, the immunostaining signal for collagen type IV in the basement membrane was 
significantly decreased in the invading epithelial cells (Fig. 4D).  These results suggest that 
chronic inflammation contributes to the submucosal invasion through macrophage-expressed 
MT1-MMP, which leads to MMP2 activation resulting in degradation of basement membrane.  
Because MT1-MMP expression was also induced in the Apc716 benign adenomas (Fig. 
1C, D), we further examined MMP activation in other mouse tumor models.  As anticipated, 
MMP2 was activated in the invasive tumors of Apc716 Tgfbr2IEC mice (Fig. 4E).  Notably, 
MMP2 activation was also found in the non-invasive benign tumors of Apc716 mice and 
AOM/DSS-treated mice, although the band intensities were lower compared with those of the 
Apc716 Tgfbr2IEC mouse invasive tumors (Fig. 4E).  These results suggest that MMP2 
activation is already induced in benign intestinal tumors, and its activation level increases with 
the progression of the tumor.  Accordingly, it is also possible that suppression of TGF 
signaling causes acquisition of invasiveness of epithelial cells in such microenvironment. 
 
Impaired mucosal regeneration by suppression of TGF signaling 
Impaired mucosal regeneration from ulcer in Tgfbr2IEC mice (Fig. 2B, C) suggested a 
role of TGF signaling in regeneration of injured intestinal mucosa.  To test this possibility, 
mice were irradiated with X-ray at 9 Gy.  In the irradiated wild-type mice, the number of 
proliferating cells in the crypt decreased on days 1-3 after irradiation, followed by destruction 
of the mucosal structure by day 4 (Supplementary Fig. S4).  At the same time, the 
undifferentiated cell population expanded, and normal crypt-villous structures were 
regenerated by day 6, which was consistent with a previous report (28).  X-ray irradiation in 
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Tgfbr2IEC mice also showed a decrease in the proliferating crypt cell population, followed by 
increased numbers of proliferating undifferentiated cells (Supplementary Fig. S4).  However, 
the extent of the injury was more severe in the Tgfbr2IEC mice, and the regeneration of the 
normal mucosal structure was impaired in both the small intestine and colon (Fig. 5A and 
Supplementary Fig. S5).  Because of such severe phenotypes, most irradiated Tgfbr2IEC 
mice died by day 7 (Fig. 5B).  Moreover, markers of undifferentiated epithelial cells, CD44 
and SOX7, were expressed in the entire intestinal mucosa of the X-ray-irradiated Tgfbr2IEC 
mice, whereas their expression was limited to the crypt bottom in the wild-type mice (Fig. 5A 
and Supplementary Fig. S5B).  Consistently, an intestinal progenitor cell marker, SOX9 (29), 
was upregulated in the intestine by irradiation, and the SOX9 level was significantly higher in 
Tgfbr2IEC mice than in wild-type mice (Fig. 5C).  Moreover, the nuclear accumulation and 
stabilization of -catenin was not found in the irradiated Tgfbr2IEC mouse intestinal epithelia 
(Figs. 5D and E).  Taken together, these results indicate that TGF signaling is required for 
differentiation of regenerating epithelial cells, and that blocking TGF pathway causes 
expansion of the proliferating and undifferentiated epithelial cell population without activation 
of Wnt signaling. 
 
Acquisition of invasive phenotype by blocking TGF signaling in regenerating 
epithelial cells 
We next studied the effect of TGF signaling suppression in regenerating mucosa on 
invasive phenotype.  Organoid culture of the irradiated wild-type mouse-derived intestinal 
epithelial cells showed budding from cysts, forming mini-crypt structures (Fig. 6A), which was 
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consistent with the original report (18).  Importantly, intestinal epithelial cells derived from 
irradiated Tgfbr2IEC mice formed gland-like long crypt structures in the Matrigel (Fig. 6A).  
We further examined the epithelial cell proliferation in the organoids by evaluating the EdU 
incorporation to nuclei, and examined the undifferentiated status by determining the CD44 
expression.  Notably, the expression of EdU and CD44 was found in the epithelial cells along 
the long crypts of Tgfbr2IEC mouse-derived organoids, although that was detected only in 
budding crypts of wild-type organoids.  These results suggest that the long crypts are 
comprised of proliferating undifferentiated epithelial cells.  The proportion of long crypts > 
200 m was significantly higher in the irradiated Tgfbr2IEC mouse-derived intestinal epithelial 
cells (42  13% of all crypts) compared with epithelial cells derived from irradiated Tgfbr2flox/flox 
control mice (3.9  4.5%) (Fig. 6B).  Such long crypt formation was not found also in 
organoids of non-irradiated Tgfbr2IEC mouse-derived intestinal epithelial cells.  It is possible 
that long crypt formation in Matrigel reflects “collective cell migration” in the extracellular 
matrix, which is one of strategies used by cancer cells for invasion (30).  Therefore, it is 
conceivable that suppression of TGF signaling in regenerating mucosa results in the 
acquisition of invasive phenotype, which leads to collective migration in the inflammatory 
microenvironment.   
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Discussion 
Genome-wide analyses have indicated that accumulation of genetic alterations in 
oncogenic and tumor suppressor pathways is responsible for development of colon cancer 
(31).  On the other hand, the nature and significance of the individual genetic alterations are 
not yet understood (32).  In addition, relatively few mutations have been identified that are 
responsible for invasion and/or metastasis (8, 33), suggesting that microenvironment can 
promote malignant progression.  We have herein demonstrated that simple genetic 
alterations in the TGF pathway can lead to the development of invasive gastrointestinal 
cancers without additional genetic alterations when the mucosa is inflamed and regenerating 
from injury (Fig. 7A). 
It has been shown that suppression of TGF signaling in the intestinal and mammary 
gland tumor cells induces chemokine expression, which recruits myeloid cells to the tumor 
microenvironment (12, 14).  These myeloid cells express metalloproteinases, such as 
MT1-MMP, MMP2 and MMP9 that contribute to the invasion or metastasis of tumor cells.  
These results suggest that elaboration of an inflammatory microenvironment is critical for the 
malignant progression mediated by inhibition of the TGF signaling.  We also found that 
MMP2 is activated by macrophage-expressing MT1-MMP in the invasive tumors.  However, 
we found that MMP2 is activated also in the benign intestinal tumor tissues with intact TGF 
signaling.  Accordingly it is conceivable that the acquisition of an invasive phenotype by 
epithelial cells is further required for malignant progression where TGF signaling is 
suppressed. 
Blocking TGF signaling in the intestinal epithelial cells did not cause morphological 
 18
changes, indicating that TGF signaling is not required for differentiation of normal intestinal 
stem/progenitor cells (20, 22).  However, we found that suppression of TGF signaling in the 
injured intestinal mucosa blocked mucosal regeneration by suppressing differentiation, which 
caused the expansion of undifferentiated cell population.  Accordingly, TGF signaling is 
essential for regeneration from damaged mucosa in the gastrointestinal tract.  Notably, 
intestinal epithelial cells derived from irradiated Tgfbr2IEC mice showed increased invasion in 
Matrigel, possibly caused by expansion of undifferentiated epithelial cell population.  
However, irradiation of Tgfbr2IEC mice caused only dysplastic changes without tumor 
development, indicating that blocking TGF signaling in regenerating epithelial cells alone is 
insufficient for induction of invasive tumors.   
Accordingly, it is required for the development of invasive tumors that both the 
inflammatory microenvironment where MT1-MMP is expressed and the regenerating 
epithelial cells with increased invasiveness by inhibition of TGF signaling (Fig. 7A).  Such a 
mechanism is possibly important for cancer development associated with IBD.  In IBD 
lesions, the mucosa is continuously regenerating in a chronic inflammatory microenvironment, 
and the expression of MT1-MMP, together with inflammatory chemokines, is upregulated 
similar to that observed in Tgfbr2IEC mouse tumors (Supplementary Fig. S6).  Furthermore, 
we herein demonstrated that TGF signaling is suppressed and Wnt signaling is not activated 
in more than 60% of UC-related colon cancer cells.  Consistently, it has also been reported 
that human colitis-associated colon cancer does not follow the adenoma-carcinoma sequence, 
and mutations in -catenin or APC are not common either (34).  Accordingly, simple genetic 
alterations in the TGF signaling pathway may cause the development of invasive tumors 
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under IBD condition (Fig. 7A).   
On the other hand, compound mutant mice carrying mutations in Apc and TGF 
pathway genes showed progression of invasive adenocarcinomas from Wnt activated 
adenomas (19-21), indicating that the combination of Wnt activation and TGF signaling 
suppression is sufficient for malignant progression.  In the regenerating mucosa, stem cell 
population is expanded, with the signaling in the Wnt and Notch pathways activated (35).  It 
is therefore possible that the activation of Wnt signaling is necessary for malignant 
progression in sporadic tumors where TGF signaling is blocked without mucosa 
regeneration.  Accordingly, combination of Wnt activation and TGF suppression in the 
MT1-MMP-expressing inflammatory microenvironment is sufficient for the induction of 
invasive adenocarcinoma in normal intestine (Fig. 7B). 
In conclusion, we have demonstrated that suppression of TGF signaling in the 
regenerating epithelial cells results in suppression of epithelial differentiation and acquisition 
of invasive phenotype of epithelial cells.  Chronic inflammation induces development of an 
MMP2-activating microenvironment.  The cooperation between TGF signaling suppression 
in the regenerating epithelia and the inflammatory microenvironment can cause invasive 
colon cancer development, which may explain mechanism of IBD-associated colon 
tumorigenesis.  Therefore, controlling the inflammatory microenvironment may help an 
effective preventive or therapeutic strategy against the malignant progression of colon cancer. 
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Figure 1. Size-dependent submucosal invasion of intestinal tumors.  (A) Representative 
photographs of Apc716 mouse benign adenomas (left) and Apc716 Tgfbr2IEC mouse invasive 
adenocarcinomas (right).  H&E (top) and enlarged images of the boxed areas (middle), and 
fluorescence immunohistochemistry for E-cadherin (red) and SMA (green) (bottom).  T, 
tumor; and SM, submucosa.  Arrowheads indicate submucosal invasion of tumor epithelial 
cells.  Bars, 400 m (top) and 200 m (middle and bottom).  (B) Size classification of 
intestinal tumors of Apc716 mice (top) and Apc716 Tgfbr2IEC mice (bottom) scored using 
“Swiss roll” histology sections.  Each dot indicates an individual polyp.  Different colors 
indicate independent mice.  (C) Representative photographs of non-invasive (top) and 
invasive polyps (bottom) of Apc716 Tgfbr2IEC mice.  H&E staining, immunohistochemistry for 
F4/80 and MT1-MMP, and Masson’s trichrome staining (MT) (left to right).  Insets indicate 
high-powered magnification.  Bars, 200 m (top) and 400 m (bottom).  (D) Expression 
levels of the indicated factors relative to the mean level of normal mucosa in size-classified 
small intestinal and colon tumors of Apc716 mice (mean  s.d.).  Asterisks, P < 0.05 
compared with the normal mucosal level. 
 
Figure 2.  Submucosal invasion of TGF signaling-suppressed cells by ulcerative colitis.  
(A) Schedule for Tmx and DSS treatment and examination of mice.  (B) Representative 
photographs (H&E) of DSS-treated wild-type (left) and DSS-treated Tgfbr2IEC (right) mouse 
colons three days (top) and four weeks (down) post-treatment.  Arrows (top) indicate ulcer 
lesions.  Arrowheads (bottom right) indicate submucosal invasion of epithelial cells.  
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Asterisk indicates impaired regeneration of the normal gland structure.  Bars, 200 m.  (C) 
Representative photographs of serial sections of invasive tumors of a DSS-treated Tgfbr2IEC 
mouse 10 weeks post-treatment.  H&E (top), Masson’s trichrome (MT) staining (middle) and 
enlarged images of the boxed areas (bottom).  Arrows indicate the location of muscularis 
mucosae.  Asterisks indicate impaired regeneration of the normal gland structure.  Bars, 
500 m (top and middle) and 200 m (bottom).  (D) Representative macroscopic 
photographs of invasive tumors developed in a DSS-treated Tgfbr2IEC mouse at 40 weeks 
post-treatment (arrows, top left), and the H&E (top right) and immunohistochemistry for Ki67 
(bottom).  Arrows (bottom) indicate the location of muscularis mucosae, and inset indicates 
an enlarged image of the boxed area.  Ce, cecum; Ile, ileum and Co, colon.  Bars, 2 mm 
(top) and 400 m (bottom).  (E) Immunoblotting for active -catenin and total -catenin in the 
intestinal mucosa and polyps in Apc716 and AOM/DSS-treated mice (left) and DSS-treated 
Tgfbr2IEC mice (right) at the indicated time points.  NM, normal mucosa; and inv, invasive 
tumors.  -Actin was used as an internal control.  (F) Representative immunohistochemical 
findings of p-Smad2 in UC-associated human colon cancer tissues (left, center), and the 
-catenin in sporadic colon cancer (right top) and UC-associated colon cancer (UC) (right 
bottom).  Arrows (center) indicate surface epithelial cells and invading tumor cells.  Bars, 
500 m (left) and 50 m (center and right).   
 
Figure 3. Chronic inflammation in invasive tumors of Tgfbr2IEC mice.  (A) Representative 
photographs of immunohistochemistry for GFP in a DSS-treated Tgfbr2IEC mouse that had 
undergone bone marrow transplantation from a GFP transgenic mouse (top).  Enlarged 
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images of invasive (bottom left) and non-invasive (bottom center) mucosa of the boxed areas 
(top).  Fluorescent immunostaining for F4/80 (green) and E-cadherin (red) in an invasive 
tumor (bottom right).  Bars, 400 m (top) and 200 m (bottom).  (B) Relative expression 
levels of the indicated chemokines in the invasive tumors in DSS-treated Tgfbr2IEC mice to 
the mean level of wild-type mouse colons (mean  s.d.).  Asterisks, P < 0.05.  (C) 
Immunoblotting for phosphorylated Stat3 and total Stat3 in the colon mucosa of control 
wild-type mice (WT), DSS-treated wild-type and Tgfbr2IEC mice.  -Actin was used as an 
internal control.  uc, ulcerative colitis; rep, repaired mucosa; and inv, invasive tumor.  The 
band intensities for pStat3/Stat3 relative to the mean level of wild-type mice (WT) (red bar) are 
shown in a bar graph (C, bottom).  (D) Expression levels of cytokines, chemokines and 
COX-2 in DSS-treated wild-type or Tgfbr2IEC mouse colonic mucosa relative to the mean 
levels of the repaired mucosa (green) (mean  s.d.).  Asterisks, P < 0.05.  ns, not 
significant.   
 
Figure 4. Expression of MT1-MMP and activation of MMP2 in invasive tumors.  (A) 
Expression levels of indicated MMPs in the DSS-treated Tgfbr2IEC mouse invasive tumors 
(red) relative to the level of repaired mucosa of DSS-treated wild-type mice (green) (mean  
s.d.).  Asterisks, P < 0.05 versus wild-type level.  (B) Fluorescent immunostaining of the 
invasive tumors in DSS-treated Tgfbr2IEC mice for E-cadherin (green), MT1-MMP (red) (left), 
and F4/80 (green) and MT1-MMP (red) (right).  Insets indicate enlarged images of the boxed 
areas.  Bars, 200 m.  (C) Gelatin zymography of the normal mucosa (N1-N3) and invasive 
tumors (T1-T3) of three individual DSS-treated Tgfbr2IEC mice.  Latent MMP9 and MMP2 
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were used as positive controls.  (D) Immunostaining for collagen type IV in the invasive colon 
tumors of DSS-treated Tgfbr2IEC mice.  White arrowheads indicate invading epithelial cells 
in submucosa, whereas closed arrowheads indicate non-invading epithelial cells.  Bars, 50 
m.  (E) Gelatin zymography of the normal intestinal mucosa (N1-N2) and intestinal 
adenomas (A1-A2) of Apc716 mice, invasive adenocarcinomas (C1-C2) of Apc716 Tgfbr2IEC 
mice, ulcerative colitis tissues of DSS-treated wild-type mice (I1-I2), repaired mucosa of 
DSS-treated wild-type mice (R1-R2) and non-invasive colon tumors (T1-T2) of 
AOM/DSS-treated wild-type mice.  Coomassie Brilliant Blue staining of the 40 kDa bands are 
shown at the bottom of the zymography gels as a protein level control (C, E).  Relative band 
intensities for active MMP2 to the mean level of Apc716 adenomas (red bar) are shown in a 
bar graph (E, bottom). 
 
Figure 5. Impaired mucosal regeneration by suppression of TGF signaling.  (A) 
Representative photographs of X-ray-irradiated wild-type (top) and Tgfbr2IEC (bottom) mouse 
small intestines six days post-irradiation.  H&E staining, fluorescence immunostaining for 
E-cadherin (red) and Ki67 (green), immunohistochemistry for CD44 and SOX7 (left to right) 
are shown.  White arrowheads indicate Ki67-positive cells.  Arrows and closed arrowheads 
indicate CD44- and SOX7-positive epithelial cells, respectively.  Bars, 200 m (left) and 100 
m (center and right).  (B) Survival curve of wild-type and Tgfbr2IEC mice after X-ray 
irradiation at 9 Gy.  (C) Expression levels of SOX9 in X-ray-irradiated wild-type (gray bars) 
and Tgfbr2IEC (closed bars) mouse intestines relative to the mean level of non-irradiated 
wild-type mice (Day 0) (mean  s.d.).  Asterisks, P < 0.05 versus Day 0 level, and the dagger 
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indicates P < 0.05.  ns, not significant.  (D) Immunohistochemical staining for -catenin in 
an Apc716 mouse intestinal polyp (left) and irradiated Tgfbr2IEC mouse small intestinal 
mucosa (right).  White arrowheads indicate -catenin nuclear accumulation.  Bar, 25 m.  
(E) Immunoblotting for active -catenin and total -catenin in the indicated intestinal tissues.  
-Actin was used as an internal control. 
 
Figure 6. Acquisition of invasive phenotype by TGF inhibition in regenerating epithelia.  (A) 
Representative bright field photographs of organoid cultures in Matrigel (left) and confocal 
images of organoids immunostained for EdU (red) and CD44 (green) (right) of wild-type (top) 
and X-ray-irradiated Tgfbr2IEC (bottom) mouse intestinal epithelia.  Arrowheads indicate 
EdU negative and CD44 weak cells in wild-type organoid.  Bars, 200 m (left) and 50 m 
(right).  (B) The crypt lengths of organoids derived from wild-type and non-irradiated 
Tgfbr2IEC mice (light blue), irradiated Tgfbr2flox/flox (control) mice (blue) and irradiated 
Tgfbr2IEC mice (red).  Red bar indicates 200 m threshold, and crypts longer than 200 m 
were judged to be long crypts. 
 
Figure 7. A schematic drawing of the TGF signaling suppression-induced invasive tumor 
development in regenerating and inflamed mucosa (A) and in Wnt signaling-activated 
adenomas (B). 







